SUZ Stock Analysis: Suzano Papel e Celulose | NYSE
Paper & Paper Products | NYSE, USA | Market Cap: 10.554m USD | 12M Return: -7.8% | US86959K1051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.3M
Qual. Beats: 0
Rev. Trend: 78.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Suzano S.A., listed on the NYSE under the ticker SUZ, is a Brazilian manufacturer of pulp and paper products with operations both domestically and internationally. The company operates through two main segments: Cellulose and Paper, offering a diverse range of products including coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps. Beyond its core manufacturing activities, Suzano is involved in a broad array of businesses, such as biofuel research and production, port terminal operations, power generation, and the development of biotechnology and nanocrystalline pulps. The company also explores cellulose-based innovations, including fibers, yarns, textile filaments, and lignin research, reflecting its commitment to expanding the applications of its core materials. Founded in 1924 and headquartered in Salvador, Brazil, Suzano was previously known as Suzano Papel e Celulose S.A. before rebranding in April 2019. As a large-cap company in the Materials sector, specifically within the Paper Products sub-industry, Suzano plays a significant role in the global pulp and paper market.
- Eucalyptus pulp prices surge on constrained global supply
- Brazilian real weakness lifts dollar-denominated export revenue margins
- Cerrado project ramp-up expands market pulp capacity by millions of tonnes
| Net Income: 8.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.83 > 1.0 |
| NWC/Revenue: 68.21% < 20% (prev 53.20%; Δ 15.01% < -1%) |
| CFO/TA 0.10 > 3% & CFO 16.9b > Net Income 8.21b |
| Net Debt (77.5b) to EBITDA (29.2b): 2.65 < 3 |
| Current Ratio: 3.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.24b) vs 12m ago 0.25% < -2% |
| Gross Margin: 27.94% > 18% (prev 37.73%; Δ -9.79% > 0.5%) |
| Asset Turnover: 29.25% > 50% (prev 32.18%; Δ -2.93% > 0%) |
| Interest Coverage Ratio: 2.59 > 6 (EBIT TTM 17.3b / Interest Expense TTM 6.67b) |
| A: 0.19 (Total Current Assets 46.8b - Total Current Liabilities 13.9b) / Total Assets 171b |
| B: 0.04 (Retained Earnings 6.12b / Total Assets 171b) |
| C: 0.10 (EBIT TTM 17.3b / Avg Total Assets 165b) |
| D: 0.41 (Book Value of Equity 49.6b / Total Liabilities 121b) |
| Altman-Z'' = 2.52 = A |
| DSRI: 1.06 (Receivables 8.70b/8.73b, Revenue 48.3b/51.3b) |
| GMI: 1.35 (GM 37.73% / 27.94%) |
| AQI: 0.52 (AQ_t 0.16 / AQ_t-1 0.31) |
| SGI: 0.94 (Revenue 48.3b / 51.3b) |
| TATA: -0.05 (NI 8.21b - CFO 16.9b) / TA 171b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of October 03, 2026, the stock is trading at USD 8.50 with a total of 1,931,315 shares traded. Over the past week, the price has changed by -2.19%, over one month by -7.00%, over three months by +7.87% and over the past year by -7.77%.
Current recommended Stop Loss: 7.90 (which is 7.1% or 2.6 ATR below the current price).
Suzano Papel e Celulose has received a consensus analysts rating of 4.60. Therefore, it is recommended to buy SUZ.
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.6 | 47.8% |
Market Cap BRL = 55.1b (10.6b USD * 5.2223 USD.BRL)
P/E Trailing = 6.856
P/E Forward = 7.776
P/S = 0.2207
P/B = 1.167
Revenue TTM = 48.3b BRL
EBIT TTM = 17.3b BRL
EBITDA TTM = 29.2b BRL
Long Term Debt = 88.4b BRL (from longTermDebt, last quarter)
Short Term Debt = 2.94b BRL (from shortTermDebt, last quarter)
Debt = 104b BRL (from shortLongTermDebtTotal, last quarter) + Leases 6.71b
Net Debt = 77.5b BRL (calculated: Debt 104b - CCE 26.2b)
Enterprise Value = 133b BRL (55.1b + Debt 104b - CCE 26.2b)
Interest Coverage Ratio = 2.59 (Ebit TTM 17.3b / Interest Expense TTM 6.67b)
EV/FCF = 26.47x (Enterprise Value 133b / FCF TTM 5.01b)
FCF Yield = 3.78% (FCF TTM 5.01b / Enterprise Value 133b)
FCF Margin = 10.38% (FCF TTM 5.01b / Revenue TTM 48.3b)
Net Margin = 17.00% (Net Income TTM 8.21b / Revenue TTM 48.3b)
Gross Margin = 27.94% ((Revenue TTM 48.3b - Cost of Revenue TTM 34.8b) / Revenue TTM)
Gross Margin QoQ = 22.87% (prev 28.82%)
Tobins Q-Ratio = 0.78 (Enterprise Value 133b / Total Assets 171b)
Interest Expense / Debt = 6.43% (Interest Expense 6.67b / Debt 104b)
Taxrate = 33.50% (4.15b / 12.4b)
NOPAT = 11.5b (EBIT 17.3b * (1 - 33.50%))
Current Ratio = 3.38 (Total Current Assets 46.8b / Total Current Liabilities 13.9b)
Debt / Equity = 2.09 (Debt 104b / totalStockholderEquity, last quarter 49.6b)
Debt / EBITDA = 2.65 (Net Debt 77.5b / EBITDA 29.2b)
Debt / FCF = 15.47 (Net Debt 77.5b / FCF TTM 5.01b)
Total Stockholder Equity = 46.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.97% (Net Income 8.21b / Total Assets 171b)
RoE = 17.61% (Net Income TTM 8.21b / Total Stockholder Equity 46.6b)
RoCE = 12.80% (EBIT 17.3b / Capital Employed (Equity 46.6b + L.T.Debt 88.4b))
RoIC = 7.30% (NOPAT 11.5b / Invested Capital 157b)
WACC = 5.55% (E(55.1b)/V(159b) * Re(7.94%) + D(104b)/V(159b) * Rd(6.43%) * (1-Tc(0.34)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -78.18 | Cagr: -1.65%
[DCF] Terminal Value 73.10% ; FCFF base≈5.40b ; Y1≈4.74b ; Y5≈3.83b
[DCF] Fair Price = N/A (negative equity: EV 61.4b - Net Debt 77.5b = -16.0b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.03 | # QB: 0
Revenue Correlation: 78.79 | Revenue CAGR: 10.85% | SUE: -0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=1.71 | Chg30d=+10.92% | Revisions=+25% | GrowthEPS=-17.9% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=1.12 | Chg30d=+10.79% | Revisions=+25% | GrowthEPS=-34.4% | GrowthRev=+14.3%